The dictates of the in vitro diagnostic regulation (IVDR) and “bureaucratic” issues are dampening the industry’s innovation ...

The market is projected to expand at a compound annual growth rate of 6% from 2024 to 2034. Growing clinical evidence is ...

Siemens has announced plans to ‘deconsolidate’ its remaining stake in Siemens Healthineers by transferring 30% of shares to ...

Zimmer Biomet has received 510(k) clearance from the US Food and Drug Administration (FDA) for ROSA Knee with OptimiZe ...

Biogen has completed the acquisition of Alcyone Therapeutics, for $85m upfront payment, to boost central nervous system (CNS) ...